This year's Oncology Nursing Society (ONS) Congress featured numerous thought-provoking and motivating presentations from experts in the field of oncology nursing. Maria Badillo, Research Nurse Manager at MD Anderson Cancer Center and Editorial Board Member of Oncology Data Advisor®, stopped by in between presentations to share the most inspiring t...

In this Oncology Data Advisor® Fellows Forum Interview, Dr. Richa Thakur, Hematology/Oncology (Heme/Onc) Fellow at Northwell Health, outlines the need for palliative care education in the oncology setting and shares valuable resources for fellows who are interested in expanding their knowledge of palliative care and hospice to better serve their patients.  

In this interview, Oncology Data Advisor® is joined by Dr. Christine Ko, Professor of Dermatology and Pathology at Yale University and host of the See, Hear, Feel podcast. Dr. Ko shares her passion for incorporating cognitive psychology and emotional intelligence into medical practice and explains how doing so can enhance patient encounters and care.  

At the 48th Annual Oncology Nursing Society (ONS) Congress, Dr. Megan Mullins, an Assistant Professor at the University of Texas (UT) Southwestern Cancer Center, gave a presentation on improving cancer survivorship for sexual and gender minorities. In this follow-up interview, she shares the ongoing efforts into improving cancer survivorship care for these populations, as well as advice and resources for clinicians for creating welcoming spaces for LGBTQ+ cancer patients and survivors.  

In this interview from the Oncology Nursing Society (ONS) 2023 Congress, Oncology Data Advisor speaks with Lauren Ghazal, PhD, FNP-BC, a Family Nurse Practitioner and Post-Doctoral Research Fellow at the University of Michigan. Dr. Ghazal was honored at ONS Congress as a recipient of the 2023 Mara Mogensen Flaherty Memorial Lectureship Award to discuss "Current Challenges: Nursing Sustainability" along with fellow recipients Suzanne Carroll, RN, MS, AOCN®; Amy E. Rettig, DNP, MALM, MSN, BSN, RN ACNS-BC, PMHNP-BC; and 2000 Mara Mogensen Flaherty Memorial Lectureship Award recipient Debi Boyle, MSN, RN, AOCNS®,FAAN, serving as moderator. In this interview, Dr. Ghazal highlights her inspiring work and research investigating nursing sustainability and cancer survivorship for adolescents and young adults, and shares how to encourage more individuals to pursue a fulfilling career in nursing and research.  

The 2023 winner of the CURE Extraordinary Healer® Award, announced at the recent Oncology Nursing Society (ONS) Congress in San Antonio, Texas, is Abbey Kaler, MS, APRN, FNP-C, Advanced Practice Registered Nurse in the Advanced Breast Cancer Program at the University of Texas MD Anderson Cancer Center. After the excitement of her win, Ms. Kaler sat down with Oncology Data Advisor to reflect on her passion for oncology nursing and for being able to connect with patients and help them through their journeys.  

Recently, the Oncology Nursing Certification Corporation (ONCC) unveiled its new logo, which embraces the diversity and the passion behind oncology nursing. In this interview, Tony Ellis, MSEd, CAE, ICE-CCP, the Executive Director of ONCC, shares the features of their recently rebranded website and the benefits of obtaining ONCC certification, as well as steps and tips for nurses who are interested in becoming certified.  

Oncology Data Advisor® is excited to announce the launch of the Fellows Forum, a new resource featuring expert perspectives geared toward Hematology/Oncology Fellows. In this interview, Dr. Sunil Iyer, Chief Hematology/Oncology Fellow at the University of Miami, Florida, discusses his leukemia research, exciting new treatment directions, and what t...

Oncology Data Advisor® is excited to announce the launch of the Fellows Forum, a new resource featuring expert perspectives geared toward Hematology/Oncology Fellows. In this interview, Dr. Samuel Kareff, Chief Hematology/Oncology Fellow at the University of Miami's Sylvester Cancer Center, shares the educational topics that he is looking forward to sharing his insights on as a Fellows Forum member, including tips for fellowship application, specialty pros and cons, research advances, and collaborations with policymakers and patient advocacy groups.  

In this interview for National Minority Health Month, Oncology Data Advisor speaks with Dr. Ian Bouligny, a third-year Hematology/Oncology Fellow at Virginia Commonwealth University (VCU) Massey Cancer Center. Dr. Bouligny shares updates on his research regarding health care barriers faced by patients of minority populations with acute myeloid leukemia (AML) and suggests questions that clinicians can ask their patients to ensure proper treatment support and accessibility.  

This interview is the first in a new series spotlighting the Oncology Data Advisor® Editorial Board, featuring Dr. Richard Carvajal, Director of Medical Oncology at Northwell Health Cancer Institute. Dr. Carvajal tells the story of how he became a melanoma researcher and shares his passions for developing targeted therapies for unique clinical subsets of melanoma and for providing high-quality cancer care for patients in their own neighborhoods.  

In honor of National Minority Health Month, Dr. Shakira Grant, Assistant Professor at the University of North Carolina at Chapel Hill, sat down with Oncology Data Advisor to talk about her research surrounding racial disparities faced by patients with multiple myeloma. Dr. Grant outlines the existing barriers to equitable health care and shares valuable advice on steps that oncology clinicians can take to make health care more accessible for their patients of minority populations.  

At the recent American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, Dr. Lisa Gudenkauf, an Applied Research Scientist at Moffitt Cancer Center, presented her team's research regarding the Functional Assessment of Cancer Therapy—Radionuclide Therapy (FACT-RNT), a novel patient-reported outcomes (PRO) measure for patients with prostate cancer. In this follow-up interview, Dr. Gudenkauf shares more about how the measure was developed, its importance for capturing the patient experience, and its future implementation into both clinical practice and trials.  

Recently, Ravi Parikh, MD, MPP, an Assistant Professor of Medical Ethics and Health Policy and Medicine at the University of Pennsylvania, Perelman School of Medicine, released a research letter titled, "Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval." In this interview with Onc...

Last year, Dr. Ticiana Leal, Director of the Thoracic Medical Oncology Program at Winship Cancer Institute of Emory University, recorded a continuing medical education (CME)/nursing continuing professional development (NCPD)–accredited activity titled Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer (NSCLC). With nu...

In honor of Rare Disease Day on February 28, the Oncology Data Advisor Editorial Board held a live panel discussion that featured updates on rare gastrointestinal cancers from Dr. Thomas Abrams, Assistant Professor of Medicine at Harvard Medical School; perspectives on nursing management of mantle cell lymphoma from Maria Badillo, Research Nurse Manager at MD Anderson Cancer Center; and updates on rare genitourinary cancers from Dr. Ulka Vaishampayan, Professor of Internal Medicine at the University of Michigan Rogel Cancer Center.  

Just under a year ago, Beth Sandy, a Thoracic Oncology Nurse Practitioner, co-led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity, Harnessing Immunotherapy-Based Strategies For Advanced Non–Small Cell Lung Cancer (NSCLC). In this interview, she provides an update on advancements made in trea...

In 2022, Allison Imahiyerobo, an Advanced Practice Nurse at the Englewood Health Physician Network in New Jersey, led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity with i3 Health, New Insights and Avenues for Improved Patient Outcomes in Immune Thrombocytopenia. A year later, Ms. Imahiyero...

At this weekend's American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancer Symposium, Dr. Josep Tabernero, Director of the Vall d'Hebron Institute of Oncology, presented results of the phase 3 SUNLIGHT trial of trifluridine/tipiracil plus bevacizumab for patients with metastatic colorectal cancer. In this interview, Dr. Tabernero further elaborates on the significance of this treatment combination and its emerging role in the treatment landscape.  

In 2022, Dr. Mark Kris, the William and Joy Ruane Chair in Thoracic Oncology at Memorial Sloan Kettering Cancer Center, served as chair of Optimizing Management of Metastatic Squamous Non–Small Cell Lung Cancer (NSCLC), a continuing medical education (CME)/nursing continuing professional development (NCPD) activity. A year later, Dr. Kris sat down again with Oncology Data Advisor to share the progress that has occurred in this field and the important considerations to keep in mind when treating patients with squamous NSCLC in 2023.